Versa Vascular

Versa Vascular is a structural heart disease treatment company developing an implant system designed to treat tricuspid regurgitation by supporting native valve function without disrupting cardiac structures. The company’s system provides a steerable catheter for implant placement, simplified device control, and an atrial-only implant design, enabling cardiologists to treat a broader range of patients, reduce procedural risks, and improve outcomes. Versa Vascular is committed to transforming the treatment landscape for tricuspid valve insufficiency with its innovative transcatheter tricuspid valve repair system. Its novel transcatheter tricuspid valve repair system under development not only achieves smaller size, lighter weight, and lower manufacturing costs but also significantly enhances delivery efficiency through optimized occlusion structure.